Editing Phenytoin (section)

===Economics===
Phenytoin is available as a generic medication.<ref name=Ric2013/>

Since September 2012, the marketing licence in the UK has been held by Flynn Pharma Ltd, of Dublin, [[Ireland]], and the product, although identical, has been called Phenytoin Sodium ''xx''mg Flynn Hard Capsules. (The ''xx''mg in the name refers to the strength—for example "Phenytoin sodium 25&nbsp;mg Flynn Hard Capsules").<ref>{{cite web | title = Phenytoin Sodium Flynn Hard Capsules...Marketing authorisation holder | work = Flynn Pharma patient information leaflet at the electronic Medicines Compendium | date = 24 April 2014 | url = https://www.medicines.org.uk/emc/medicine/28811/SPC/Phenytoin+Sodium+Flynn+Hard+Capsules+25mg%2C+50mg%2C+100mg+and+300mg/ | archive-url = https://web.archive.org/web/20170115195136/https://www.medicines.org.uk/emc/medicine/28811/SPC/Phenytoin+Sodium+Flynn+Hard+Capsules+25mg%2C+50mg%2C+100mg+and+300mg/ | archive-date=15 January 2017 | access-date = 13 May 2014 }}</ref>  The capsules are still made by [[Pfizer]]'s Goedecke subsidiary's plant in [[Freiburg]], Germany, and they still have Epanutin printed on them.<ref>{{cite web | url = https://www.mediguard.org/alerts/alert/2235.html | title = Healthcare Professionals Advised That Epanutin Capsules Are Only To Be Available Under The Generic Name | publisher = MediGuard | location = Durham, NC | date = 2 October 2012 | archive-url = https://web.archive.org/web/20140514054718/https://www.mediguard.org/alerts/alert/2235.html | archive-date=14 May 2014 | access-date= 13 May 2014 }}</ref> After Pfizer's sale of the UK marketing licence to Flynn Pharma, the price of a 28-pack of 25&nbsp;mg phenytoin sodium capsules marked Epanutin rose from 66p (about $0.88) to {{GBP|15.74}} (about $25.06). Capsules of other strengths also went up in price by the same factor—2,384%,<ref>{{cite web | url = http://www.telegraph.co.uk/health/healthnews/9604683/Pharma-firm-hikes-cost-of-epilepsy-drug-24-times.html | title = Pharma firm hikes cost of epilepsy drug 24 times | vauthors = Adams S | work = Daily Telegraph | location =  London | date = 12 October 2012 | archive-url = https://web.archive.org/web/20121013041043/http://www.telegraph.co.uk/health/healthnews/9604683/Pharma-firm-hikes-cost-of-epilepsy-drug-24-times.html | access-date = 13 May 2014 | archive-date = 13 October 2012 }}</ref> costing the UK's [[National Health Service]] an extra {{GBP|43 million}} (about $68.44&nbsp;million) a year.<ref>{{cite web | url = http://www.pulsetoday.co.uk/commissioning/commissioning-topics/prescribing/price-of-anti-epilepsy-drug-rockets/20000936.article#.U3Jez6G-ZQI | title = Price of anti-epilepsy drug rockets | vauthors = Gould M | work = Pulse | location = London | date = 21 November 2012 | archive-url = https://web.archive.org/web/20121128130259/http://www.pulsetoday.co.uk/commissioning/commissioning-topics/prescribing/price-of-anti-epilepsy-drug-rockets/20000936.article | archive-date=28 November 2012 | access-date = 13 May 2014 }}</ref>  The companies were referred to the [[Competition and Markets Authority]] (CMA) who found that they had exploited their dominant position in the market to charge "excessive and unfair" prices.<ref>{{cite news| vauthors = White M |title=Pharma market abuse isn't picked up fast enough|url=http://www.hsj.co.uk/comment/pharma-market-abuse-isnt-picked-up-fast-enough/5089545.article |access-date=6 October 2015 |work=Health Service Journal |date=12 August 2015|url-status=live|archive-url=https://web.archive.org/web/20151007030951/http://www.hsj.co.uk/comment/pharma-market-abuse-isnt-picked-up-fast-enough/5089545.article#.VhPzkUpfZ1A|archive-date=7 October 2015}}</ref>

The CMA imposed a record {{GBP|84.2 million}} fine on the manufacturer Pfizer, and a {{GBP|5.2 million}} fine on the distributor Flynn Pharma and ordered the companies to reduce their prices.<ref>{{Cite press release |url=https://www.gov.uk/government/news/cma-fines-pfizer-and-flynn-90-million-for-drug-price-hike-to-nhs|title=CMA fines Pfizer and Flynn £90 million for drug price hike to NHS |publisher=www.gov.uk |access-date=7 December 2016|url-status=live |archive-url=https://web.archive.org/web/20161207081839/https://www.gov.uk/government/news/cma-fines-pfizer-and-flynn-90-million-for-drug-price-hike-to-nhs |archive-date=7 December 2016}}</ref>